logo-loader
viewLBT Innovations Limited

LBT Innovations receives second instalment of SA Government $4 million loan facility

This second drawdown, together with the cash on hand following a recent $5 million placement, means the company is well funded into 2021.

1561616593_LBT.jpg
LBT designs advanced technology solutions for the medical industry

LBT Innovations Limited (ASX:LBT) has drawn down another instalment of a $4 million loan facility provided by the South Australian Government to the company, which is a leader in medical technology automation using artificial intelligence.

These $1.5 million second instalment funds will be applied to the company's core capability areas of artificial intelligence, science and software engineering.

The $4 million facility executed on August 28, 2018, provides the company with the ability to drawdown three instalments of $1 million, $1.5 million and $1.5 million, subject to achieving operational milestones.

 

LBT chief financial officer Ray Ridge said: “The continued support of the South Australian Government is greatly appreciated and supports our insourcing of core capabilities that have enabled us to accelerate development for the APAS® Independence.

“We will continue to prudently manage our cashflow requirements to support our ongoing commercial activities.”

The low interest rate for the facility is a 2% margin above the South Australian Government cost of funds.

The South Australian Government has received a first ranking general security over the company and its assets.

READ: LBT Innovations begins new study to extend the application of its unique technology

LBT drew down the first $1 million on May 9, 2019, and the second drawdown was made after satisfying operational milestones, including the requisite number of South Australian based employees.

The funding will support the insourced core capabilities of artificial intelligence, science and software engineering.

LBT's Automated Plate Assessment System (APAS) is being commercialised through its 50%-owned joint venture company Clever Culture Systems AG (CCS) with Hettich Holding Beteiligungs- und Verwaltungs-GmbH.

The APAS instrument is based upon LBT’s intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis and interpretation of culture plates following incubation.

Quick facts: LBT Innovations Limited

Price: 0.145 AUD

ASX:LBT
Market: ASX
Market Cap: $41.47 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Archer Materials hits another milestone with Quantum devices successfully...

Archer Materials (ASX: AXE) Chief Executive Officer DR Mohammad Choucair joined Steve Darling from Proactive to bring news the company has built Qubit control devices for quantum control measurements to characterise Archer’s unique 12CQ qubit processor chip components. Choucair talks about...

7 hours, 44 minutes ago

2 min read